"Clinical Trial Network offers quality medical attention to the Houston area, while gathering data to generate industry-leading clinical research to pharmaceutical, bio-technology sponsors, and leading Contract Research Organizations."

During the past decade, Clinical Trial Network conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 31 clinical trials were completed, i.e. on average, 83.8% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 15 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Trial Network" #1 sponsor was "Pfizer" with 6 trials, followed by "Gilead Sciences" with 4 trials sponsored, "Biogen" with 3 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored and "Hoechst Marion Roussel" with 3 trials sponsored. Other sponsors include 64 different institutions and companies that sponsored additional 63 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Trial Network" #1 collaborator was "National Institute on Aging (NIA)" with 3 trials as a collaborator, "Biogen" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator and "Alzheimer's Association" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Trial Network" are "HIV Infections" (18 trials), "Alzheimer Disease" (5 trials), "Low Back Pain" (4 trials), "Alzheimer's Disease" (3 trials) and "Chronic Low Back Pain" (3 trials). Many other conditions were trialed in "Clinical Trial Network" in a lesser frequency.

Most popular intervention types in "Clinical Trial Network" are "Drug" (80 trials), "Biological" (6 trials), "Other" (5 trials), "Device" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "Zidovudine" (7 trials), "Stavudine" (6 trials), "placebo" (4 trials) and "Didanosine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Trial Network" are 84 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Clinical Trial Network". undefined are not yet recruiting, 10 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 63 completed trials in Clinical Trial Network, 1 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Trial Network, 5 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".